Sickle Cell Disease Newborn Screening—An Audit of a Twin Island State Pilot Program

The prevalence of Sickle Cell Disease (SCD) within the Caribbean region remains second only to that of West Africa. The Newborn Screening (NBS) Program in Antigua and Barbuda remains heavily dependent on grants, therefore ultimately facing sustainability challenges. Early intervention and implementa...

Full description

Bibliographic Details
Main Authors: Shivon Belle Jarvis, Edda Hadeed, Ketty Lee, Marie-Dominique Hardy-Dessources, Jennifer M. Knight-Madden, Claudine Richardson
Format: Article
Language:English
Published: MDPI AG 2023-03-01
Series:International Journal of Neonatal Screening
Subjects:
Online Access:https://www.mdpi.com/2409-515X/9/1/14
_version_ 1797611180175392768
author Shivon Belle Jarvis
Edda Hadeed
Ketty Lee
Marie-Dominique Hardy-Dessources
Jennifer M. Knight-Madden
Claudine Richardson
author_facet Shivon Belle Jarvis
Edda Hadeed
Ketty Lee
Marie-Dominique Hardy-Dessources
Jennifer M. Knight-Madden
Claudine Richardson
author_sort Shivon Belle Jarvis
collection DOAJ
description The prevalence of Sickle Cell Disease (SCD) within the Caribbean region remains second only to that of West Africa. The Newborn Screening (NBS) Program in Antigua and Barbuda remains heavily dependent on grants, therefore ultimately facing sustainability challenges. Early intervention and implementation of preventative measures post-NBS result in significant improvements in morbidity, quality of life, and survival. This audit reviewed the pilot SCD NBS Program in Antigua and Barbuda from September 2020 to December 2021. A conclusive result was received by 99% of babies eligible for screening, 84.3% of which were HbFA, whilst 9.6% and 4.6% were HbFAS and HbFAC, respectively. This was comparable to other Caribbean countries. Sickle Cell Disease was noted in 0.5% of babies screened, which translates to 1 in 222 live births. Eighty-two percent of mothers were aware of their sickle cell status, compared to 3% of fathers. The importance of instituting a quality improvement team post the initiation of a screening program and the need for a robust public education program have been demonstrated by this audit.
first_indexed 2024-03-11T06:24:12Z
format Article
id doaj.art-91dd68efa7f34852bda5c5d36dea361b
institution Directory Open Access Journal
issn 2409-515X
language English
last_indexed 2024-03-11T06:24:12Z
publishDate 2023-03-01
publisher MDPI AG
record_format Article
series International Journal of Neonatal Screening
spelling doaj.art-91dd68efa7f34852bda5c5d36dea361b2023-11-17T11:42:30ZengMDPI AGInternational Journal of Neonatal Screening2409-515X2023-03-01911410.3390/ijns9010014Sickle Cell Disease Newborn Screening—An Audit of a Twin Island State Pilot ProgramShivon Belle Jarvis0Edda Hadeed1Ketty Lee2Marie-Dominique Hardy-Dessources3Jennifer M. Knight-Madden4Claudine Richardson5Paediatric Department, Sir Lester Bird Medical Centre, Michael’s Mount, St. John’s, Antigua and BarbudaGambles Medical Centre, Friars Hill Road, St. John’s, Antigua and BarbudaLaboratory of Molecular Genetics and Inherited Disorders of Red Blood Cell, University Hospital of Guadeloupe, Guadeloupe, F.W.I, FranceUniversité des Antilles, UFR Médecine/Campus de Fouillolle-Université Paris Cité, Inserm, BIGR, 97159 Pointe-à-Pitre, FranceCaribbean Institute for Health Research-Sickle Cell Unit, The University of the West Indies, Mona, Kingston 7, JamaicaPaediatric Department, Sir Lester Bird Medical Centre, Michael’s Mount, St. John’s, Antigua and BarbudaThe prevalence of Sickle Cell Disease (SCD) within the Caribbean region remains second only to that of West Africa. The Newborn Screening (NBS) Program in Antigua and Barbuda remains heavily dependent on grants, therefore ultimately facing sustainability challenges. Early intervention and implementation of preventative measures post-NBS result in significant improvements in morbidity, quality of life, and survival. This audit reviewed the pilot SCD NBS Program in Antigua and Barbuda from September 2020 to December 2021. A conclusive result was received by 99% of babies eligible for screening, 84.3% of which were HbFA, whilst 9.6% and 4.6% were HbFAS and HbFAC, respectively. This was comparable to other Caribbean countries. Sickle Cell Disease was noted in 0.5% of babies screened, which translates to 1 in 222 live births. Eighty-two percent of mothers were aware of their sickle cell status, compared to 3% of fathers. The importance of instituting a quality improvement team post the initiation of a screening program and the need for a robust public education program have been demonstrated by this audit.https://www.mdpi.com/2409-515X/9/1/14sickle cell diseasenewborn screeningauditAntigua and Barbuda
spellingShingle Shivon Belle Jarvis
Edda Hadeed
Ketty Lee
Marie-Dominique Hardy-Dessources
Jennifer M. Knight-Madden
Claudine Richardson
Sickle Cell Disease Newborn Screening—An Audit of a Twin Island State Pilot Program
International Journal of Neonatal Screening
sickle cell disease
newborn screening
audit
Antigua and Barbuda
title Sickle Cell Disease Newborn Screening—An Audit of a Twin Island State Pilot Program
title_full Sickle Cell Disease Newborn Screening—An Audit of a Twin Island State Pilot Program
title_fullStr Sickle Cell Disease Newborn Screening—An Audit of a Twin Island State Pilot Program
title_full_unstemmed Sickle Cell Disease Newborn Screening—An Audit of a Twin Island State Pilot Program
title_short Sickle Cell Disease Newborn Screening—An Audit of a Twin Island State Pilot Program
title_sort sickle cell disease newborn screening an audit of a twin island state pilot program
topic sickle cell disease
newborn screening
audit
Antigua and Barbuda
url https://www.mdpi.com/2409-515X/9/1/14
work_keys_str_mv AT shivonbellejarvis sicklecelldiseasenewbornscreeninganauditofatwinislandstatepilotprogram
AT eddahadeed sicklecelldiseasenewbornscreeninganauditofatwinislandstatepilotprogram
AT kettylee sicklecelldiseasenewbornscreeninganauditofatwinislandstatepilotprogram
AT mariedominiquehardydessources sicklecelldiseasenewbornscreeninganauditofatwinislandstatepilotprogram
AT jennifermknightmadden sicklecelldiseasenewbornscreeninganauditofatwinislandstatepilotprogram
AT claudinerichardson sicklecelldiseasenewbornscreeninganauditofatwinislandstatepilotprogram